Expansion Trial for Axitinib In Head And Neck Cancer

Condition:   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Axitinib
Sponsor:   University of Michigan Cancer Center
Not yet recruiting - verified May 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1SP2Unv
via IFTTT